OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis

Abstract Background Despite the growing evidence on efficacy, little is known regarding the cost-utility of Vaxom/Imocur (OM-85 BV) supplementation to decrease the probability of recurrent respiratory tract infections in OM-85 BV to reduce the incidence of recurrent respiratory tract infections in c...

Popoln opis

Bibliografske podrobnosti
Main Authors: Jefferson Antonio Buendía, Diana Guerrero Patiño, Erika Fernanda Lindarte
Format: Article
Jezik:English
Izdano: BMC 2022-12-01
Serija:BMC Pulmonary Medicine
Teme:
Health economics
Public health
Healthcare
Colombia
Corticosteroids
Online dostop:https://doi.org/10.1186/s12890-022-02264-9

Internet

https://doi.org/10.1186/s12890-022-02264-9

Podobne knjige/članki